{
  "url": "https://openlegislation.uk/eu-directive-2019-983/annex",
  "json_url": "https://openlegislation.uk/eu-directive-2019-983/annex.json",
  "legislation": "eudr/2019/983",
  "legislation_title": "Directive (EU) 2019/983 of the European Parliament and of the Council of 5 June 2019 amending Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-directive-2019-983",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "In point A of Annex III to Directive 2004/37/EC, the following rows are added:\nInhalable fraction.\nInhalable fraction. Respirable fraction in those Member States that implement, on the date of the entry into force of this Directive, a biomonitoring system with a biological limit value not exceeding 0,002 mg Cd/g creatinine in urine.\nThe substance can cause sensitisation of the skin and of the respiratory tract.\nThe substance can cause sensitisation of the skin.’.\nName of agent\nEC No (1)\nCAS No (2)\nLimit values\nNotation\nTransitional measures\n8 hours (3)\nShort-term (4)\nmg/m3 (5)\nppm (6)\nf/ml (7)\nmg/m3 (5)\nppm (6)\nf/ml (7)\n‘Cadmium and its inorganic compounds\n—\n—\n0,001\n—\n—\n—\n—\n—\nLimit value 0,004 mg/m3 until 11 July 2027\nBeryllium and inorganic beryllium compounds\n—\n—\n0,0002\n—\n—\n—\n—\n—\ndermal and respiratory sensitisation\nLimit value 0,0006 mg/m3 until 11 July 2026\nArsenic acid and its salts, as well as inorganic arsenic compounds\n—\n—\n0,01\n—\n—\n—\n—\n—\n—\nFor the copper smelting sector, the limit value shall apply from 11 July 2023\nFormaldehyde\n200-001-8\n50-00-0\n0,37\n0,3\n—\n0,74\n0,6\n—\ndermal sensitisation\nLimit value of 0,62 mg/m3 or 0,5 ppm (3) for the health care, funeral and embalming sectors until 11 July 2024\n4,4′-Methylene-bis (2-chloroaniline)\n202-918-9\n101-14-4\n0,01\n—\n—\n—\n—\n—\nskin (10)",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Inhalable fraction."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "Inhalable fraction. Respirable fraction in those Member States that implement, on the date of the entry into force of this Directive, a biomonitoring system with a biological limit value not exceeding 0,002 mg Cd/g creatinine in urine."
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "The substance can cause sensitisation of the skin and of the respiratory tract."
    },
    {
      "type": "footnote",
      "label": "f4",
      "text": "The substance can cause sensitisation of the skin.’."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/2019/983/annex",
    "retrieved_at": "2026-11-01T15:21:26.297995+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}